Extraintestinal focal infections in adults with nontyphoid Salmonella bacteraemia: Predisposing factors and clinical outcome

Journal of Internal Medicine

Volumn 261, Issue 1, 2007, Pages 91-100

  Chen, P L ^a,b   Chang, C M ^a   Wu, C J ^a   Ko, N Y ^b   Lee, N Y ^a   Lee, H C ^a,b   Shih, H I ^a   Lee, C C ^a   Wang, R R ^a   Ko, W C ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bacteraemia; Extraintestinal focal infection; Nontyphoid Salmonella; Outcome

Indexed keywords

AMPICILLIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; MEROPENEM; NALIDIXIC ACID;

ADULT; AGED; ANTIMICROBIAL THERAPY; BACTEREMIA; BACTERIUM ISOLATE; CHRONIC LUNG DISEASE; COMPARATIVE STUDY; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; GASTROINTESTINAL INFECTION; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; LUNG DISEASE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; MYCOTIC ANEURYSM; OSTEOMYELITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SALMONELLA; TAIWAN; TIME SERIES ANALYSIS; UNIVARIATE ANALYSIS;

ADULT; AGED; ANEURYSM, INFECTED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGIC METHODS; FEMALE; FEVER; FOCAL INFECTION; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; OSTEOMYELITIS; SALMONELLA INFECTIONS; SHOCK, SEPTIC; TAIWAN; TREATMENT OUTCOME;

EID: 33846024695     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01748.x     Document Type: Conference Paper

References (33)

1. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001; 32: 263-9.
2. White DG, Zhao S, Sudler R et al. The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med 2001; 345: 1147-54.
3. Galofre J, Moreno A, Mensa J et al. Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia. Clin Infect Dis 1994; 18: 873-8.
4. Zaidi E, Bachur R, Harper M. Non-typhi Salmonella bacteremia in children. Pediatr Infect Dis J 1999; 18: 1073-7.
5. Grisaru-Soen G, Wysoki MG, Keller N. Risk factors for development of nontyphoid Salmonella bacteremia. Clin Pediatr (Phila) 2004; 43: 825-9.
6. Shimoni Z, Pitlik S, Leibovici L et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis 1999; 28: 822-7.
7. Weinberger M, Andorn N, Agmon V, Cohen D, Shohat T, Pitlik SD. Blood invasiveness of Salmonella enterica as a function of age and serotype. Epidemiol Infect 2004; 132: 1023-8.
8. Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 1987; 66: 349-88.
9. Ramos JM, Garcia-Corbeira P, Aguado JM, Arjona R, Ales JM, Soriano F. Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis 1994; 19: 777-80.
10. Lee SC, Yang PH, Shieh WB, Lasserre R. Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review. Clin Infect Dis 1994; 19: 693-6.
11. Hsu RB, Tsay YG, Chen RJ, Chu SH. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 2003; 36: 829-34.
12. Cohen PS, O'Brien TF, Schoenbaum SC, Medeiros AA. The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med 1978; 89: 931-2.
13. Benenson S, Raveh D, Schlesinger Y et al. The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia. Am J Med 2001; 110: 60-3.
14. Fernandez Guerrero ML, Ramos JM, Nunez A, de Gorgolas M. Focal infections due to non-typhi Salmonella in patients with AIDS: report of 10 cases and review. Clin Infect Dis 1997; 25: 690-7.
15. Chiu CH, Lin TY, Ou JT. Predictors for extraintestinal infection of non-typhoidal Salmonella in patients without AIDS. Int J Clin Pract 1999; 53: 161-4.
16. Chiu CH, Lin TY, Ou JT. Prevalence of the virulence plasmids of nontyphoid Salmonella in the serovars isolated from humans and their association with bacteremia. Microbiol Immunol 1999; 43: 899-903.
17. Threlfall EJ, Hall ML, Rowe B. Salmonella bacteraemia in England and Wales, 1981-1990. J Clin Pathol 1992; 45: 34-6.
18. Ko WC, Yan JJ, Yu WL et al. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis. Clin Infect Dis 2005; 40: 315-8.
19. Sun HY, Tseng SP, Hsueh PR et al. Occurrence of ceftriaxone resistance in ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis isolates causing recurrent infection. Clin Infect Dis 2005; 40: 208-9.
20. Lee CY, Chiu CH, Chuang YY et al. Multidrug-resistant nontyphoid Salmonella infections in a medical center. J Microbiol Immunol Infect 2002; 35: 78-84.
21. Chiu CH, Wu TL, Su LH, Liu JW, Chu C. Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000-2003. Emerg Infect Dis 2004; 10: 1674-6.
22. Wayne PN. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 15th informational supplement. CLSI document M100-S15. Villanova: CLSI, 2005.
23. Yu VL, Chiou CC, Feldman C et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37: 230-7.
24. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
25. Chen YH, Chen TP, Lu PL et al. Salmonella choleraesuis bacteremia in southern Taiwan. Kaohsiung J Med Sci 1999; 15: 202-8.
26. Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) 1971; 50: 97-112.
27. Specht EE. Hemoglobinopathic salmonella osteomyelitis. Orthopedic aspects. Clin Orthop Relat Res 1971; 79: 110-8.
28. Lim E, Koh WH, Loh SF, Lam MS, Howe HS. Non-thyphoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 2001; 10: 87-92.
29. Taylor G, Goodfield MJ. Fatal salmonellosis in systemic lupus erythematosus. Clin Exp Dermatol 1995; 20: 255-7.
30. Chiu CH, Wu TL, Su LH et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med 2002; 346: 413-9.
31. Chiu S, Chiu CH, Lin TY. Salmonella enterica serotype Choleraesuis infection in a medical center in northern Taiwan. J Microbiol Immunol Infect 2004; 37: 99-102.
32. Kauffmann F. Classification of bacteria. A realistic scheme with special reference to the classification of Salmonella and Escherichia species. Copenhagen: Munksgaard, 1975.
33. Su LH, Chiu CH, Kuo AJ et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983-1999. Epidemiol Infect 2001; 127: 207-13.